SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:prod.swepub.kib.ki.se:1929672"
 

Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:1929672" > Hepatitis C virus n...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002765naa a2200325 4500
001oai:prod.swepub.kib.ki.se:1929672
003SwePub
008240701s2002 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:19296722 URI
024a https://doi.org/10.1099/0022-1317-83-2-3692 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Brinster, C4 aut
2451 0a Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
264 1b Microbiology Society,c 2002
520 a The capacity of recombinant Semliki Forest virus particles (rSFV) expressing the hepatitis C virus non-structural protein 3 (NS3) to induce, in comparison or in combination with an NS3-expressing plasmid, specific cellular and humoral immune responses in murine models was evaluated. In vitro studies indicated that both types of vaccine expressed the expected size protein, albeit with different efficacies. The use of mice transgenic for the human HLA-A2.1 molecule indicated that the rSFV-expressed NS3 protein induces, as shown previously for an NS3 DNA vaccine, NS3-specific cytotoxic lymphocytes (CTLs) targeted at one dominant HLA-A2 epitope described in infected patients. All DNA/rSFV vaccine combinations evaluated induced specific CTLs, which were detectable for up to 31 weeks after the first injection. Overall, less than 1 log difference was observed in terms of the vigour of the bulk CTL response induced and the CTL precursor frequency between all vaccines (ranging from 1:2·6×105 to 1:1×106). Anti-NS3 antibodies could only be detected following a combined vaccine regimen in non-transgenic BALB/c mice. In conclusion, rSFV particles expressing NS3 are capable of inducing NS3-specific cellular immune responses targeted at a major HLA-A2 epitope. Such responses were comparable to those obtained with a DNA-based NS3 vaccine, whether in the context of single or combined regimens.
700a Chen, Mu Karolinska Institutet4 aut
700a Boucreux, D4 aut
700a Paranhos-Baccala, G4 aut
700a Liljestrom, Pu Karolinska Institutet4 aut
700a Lemmonier, F4 aut
700a Inchauspe, G4 aut
710a Karolinska Institutet4 org
773t The Journal of general virologyd : Microbiology Societyg 83:Pt 2, s. 369-381q 83:Pt 2<369-381x 0022-1317x 1465-2099
856u https://doi.org/10.1099/0022-1317-83-2-369
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:1929672
8564 8u https://doi.org/10.1099/0022-1317-83-2-369

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy